SCHEMBL4074653

SCHEMBL4074653

CC(C)c1c(CC(=O)O)c2c([N+](=O)[O-])cccc2n1CC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 1/20 0.43
FBP1 P09467 2/20 0.37
CCR2 P41597 1/20 0.36
APEX1 P27695 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 2/20 0.35
MEN1 O00255 1/20 0.34
ALDH1A1 P00352 1/20 0.34
KMT2A Q03164 1/20 0.34
MPO P05164 1/20 0.34
POLB P06746 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4074647 1.00 PLA2G2A (0.43) PLA2G2AFBP1CCR2APEX1KDM4E
SCHEMBL259722 0.82 ALDH1A1 (0.43) PLA2G2AKDM4ETSHRTDP1MEN1
SCHEMBL4072566 0.81 ALDH1A1 (0.41) PLA2G2AKDM4ETSHRTDP1MEN1
SCHEMBL260848 0.72 FBP1 (0.44) FBP1APEX1KDM4ETSHRTDP1
SCHEMBL260983 0.70 GAA (0.44) PLA2G2ACYP1A2ALDH1A1KMT2A
SCHEMBL2010405 0.70 PLA2G2A (0.59) PLA2G2A
SCHEMBL3535123 0.69 GPR35 (0.54) FBP1APEX1TSHRTDP1L3MBTL1
SCHEMBL2005751 0.69 PLA2G2A (0.46) PLA2G2AKDM4ETSHRTDP1L3MBTL1
SCHEMBL2979855 0.69 CCR2 (0.52) CCR2KDM4ETSHRTDP1L3MBTL1
SCHEMBL2004563 0.68 PLA2G2A (0.51) PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1793827-A4 TRICYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2009-07-29 EP disclosed
EP-1793827-A2 TRICYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2007-06-13 EP disclosed
WO-2006031491-A2 TRICYCLIC ANILIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 2006-03-23 WO disclosed